Matakus Thanks for your words of encouragement. I am cognizant of the long lead times bringing a biological to market. I was surprised at the indicated short trial for the anti smoking drug. Apparently it hasn't commenced as early as first indicated. So my suggestion would be to advise the new estimated time frame. If the company is paying for a media relations team I repeat there is a savings. I agree the development progress is noteworthy. The share price however has headed south = why? The need for a capital raising was mooted at the AGM so came as no surprise. At best these cap raisings were clumsy at best. Given that the first cap raising was at a discount to the share price I would have expected that sophisticated investors would have been identified and ready to pick up the shortfall. This was not the case and a second cap raising was done for a select group at a lower price. What a kick in the guts for those shareholders who supported the company. Perhaps an attached free option would have garnered a better response in the first cap raising. Matakus I hope your optimism bears fruit but for now I have a stack of shares in my bottom drawer. The bottom drawer is where I keep my tax losses should I need them.
IVX Price at posting:
3.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)